PARATEK PHARMACEUTICALS INC's ticker is and the CUSIP is 699374AB0. A total of 18 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $4,686 | +177.8% | 4,750,000 | +111.1% | 0.44% | +219.7% |
Q1 2023 | $1,687 | -14.5% | 2,250,000 | 0.0% | 0.14% | -18.5% |
Q4 2022 | $1,974 | -99.9% | 2,250,000 | 0.0% | 0.17% | +46.1% |
Q3 2022 | $2,035,000 | +5.0% | 2,250,000 | 0.0% | 0.12% | -5.0% |
Q2 2022 | $1,939,000 | -3.7% | 2,250,000 | 0.0% | 0.12% | +18.6% |
Q1 2022 | $2,014,000 | -2.8% | 2,250,000 | 0.0% | 0.10% | -10.5% |
Q4 2021 | $2,071,000 | +2.7% | 2,250,000 | 0.0% | 0.11% | -1.7% |
Q3 2021 | $2,016,000 | +44.1% | 2,250,000 | +50.0% | 0.12% | +56.8% |
Q2 2021 | $1,399,000 | +2.0% | 1,500,000 | 0.0% | 0.07% | -11.9% |
Q1 2021 | $1,371,000 | +5.2% | 1,500,000 | 0.0% | 0.08% | -8.7% |
Q4 2020 | $1,303,000 | -4.2% | 1,500,000 | -25.0% | 0.09% | +187.5% |
Q2 2019 | $1,360,000 | – | 2,000,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 37,825,000 | $25,876,000 | 3.78% |
PenderFund Capital Management Ltd. | 13,060,000 | $9,300,000 | 3.13% |
Telemetry Investments, L.L.C. | 1,500,000 | $1,084,000 | 3.13% |
Context Capital Management, LLC | 1,600,000 | $1,157,000 | 0.66% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 27,750,000 | $20,019,000,000 | 0.56% |
PALISADE CAPITAL MANAGEMENT, LP | 3,750,000 | $2,712,000 | 0.08% |
CAPSTONE INVESTMENT ADVISORS, LLC | 7,182,000 | $5,264,000 | 0.04% |
AQR Arbitrage LLC | 3,050,000 | $2,236,000 | 0.03% |
Teton Advisors, Inc. | 400,000 | $280,000 | 0.03% |
GABELLI FUNDS LLC | 3,750,000 | $2,629,000 | 0.02% |